A Randomized Clinical Trial of Adipose-derived Stem Cells in Treatment of Non Revascularizable Ischemic Myocardium

Exclusion Criteria

• •Unstable angina
• •Serum creatinine \>2.5 mg/dL
• •Planned or scheduled staged treatment of CAD or other interventional or surgical procedures
• •Cardiogenic shock
• •History of resuscitated sudden cardiac death; or symptomatic or sustained ventricular fibrillation or ventricular tachycardia.
• •Vascular anatomy that precludes cardiac catheterization
• •Peripheral artery disease that precludes insertion of an 8 Fr sheath
• •Severe valvular disease
• •Pregnant or nursing females
• •Known and relevant allergies or sensitivities
• •Life expectancy \<1 year
• •Participation in any other clinical research study that has not reached its primary endpoint or otherwise would interfere with the subject's participation in this study
• •Any concurrent disease or condition that, in the opinion of the investigator, would make the subject unsuitable for participation in the study.